Skip to main content

2019 Preliminary Results

investor

2019 Preliminary Results Presentation

Download Presentation

2019 Preliminary Results

Download Results

2019 Preliminary Key Stats

€58.6m
EBITDA (Post IFRS-16)
7%
Organic GP Growth YOY
14.7%
ROCE 2019
14.3c
Adjusted EPS

Group Highlights

€180.6m

2019 GP

Employees
Partnering with 7 of the top 10 pharma companies
and 6 of the top 10 medical device companies